irritable bowel syndrome. Irritable bowel syndrome
Conditions
Interventions
Intervention 1: Intervention group: The first group in the interventional study are patients who are given sertraline 50 mg daily (Abidi Pharmaceutical Company made in Iran) for one month. Interventi
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age 18 to 50 years Patient consent to participate in the study
Exclusion criteria
Exclusion criteria: Lack of patient cooperation to participate in further study History of gastrointestinal cancer History of neurological disorder Pregnancy and lactation Bipolar or bipolar patients Contraindications to the use of two drugs sertraline and nortriptyline Use of antidepressants and anti-anxiety drugs Allergy to prescription drugs Co-occurring with serious physical illnesses such as heart disease, multiple sclerosis Having a psychotic illness such as schizophrenia and related disorders Substance abuse and substance abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: At the beginning of the study and one month after the start of the intervention in patients. Method of measurement: Beck Anxiety Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZabihullah Mohaghegh
Birjand University of Medical Sciences
Outcome results
None listed